Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to $131.0 million.

  • Eastman Chemical's Depreciation & Amortization (CF) rose 155.04% to $131.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $513.0 million, marking a year-over-year increase of 78.59%. This contributed to the annual value of $513.0 million for FY2025, which is 78.59% up from last year.
  • Eastman Chemical's Depreciation & Amortization (CF) amounted to $131.0 million in Q4 2025, which was up 155.04% from $129.0 million recorded in Q3 2025.
  • In the past 5 years, Eastman Chemical's Depreciation & Amortization (CF) registered a high of $149.0 million during Q1 2021, and its lowest value of $117.0 million during Q3 2022.
  • For the 5-year period, Eastman Chemical's Depreciation & Amortization (CF) averaged around $126.8 million, with its median value being $126.5 million (2021).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first crashed by 1879.19% in 2022, then surged by 1652.89% in 2023.
  • Over the past 5 years, Eastman Chemical's Depreciation & Amortization (CF) (Quarter) stood at $122.0 million in 2021, then fell by 4.1% to $117.0 million in 2022, then increased by 0.85% to $118.0 million in 2023, then grew by 9.32% to $129.0 million in 2024, then increased by 1.55% to $131.0 million in 2025.
  • Its last three reported values are $131.0 million in Q4 2025, $129.0 million for Q3 2025, and $127.0 million during Q2 2025.